$25.39
0.58[2.34%]
At close: Apr 23
$25.39
0[0.00%]
PreMarket: 6:02PM EDT
4D Molecular Therapeutics
(NASDAQ:FDMT)4D Molecular Therapeutics Stock (NASDAQ:FDMT), Quotes and News Summary
4D Molecular Therapeutics Stock (NASDAQ: FDMT) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 1.207M |
| Day Range | - - - |
| 52 Wk Range | 9.440 - 36.250 |
| Market Cap | $1.299B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 41 |
| Short Interest | 18.88% |
| Days to Cover | 13.84 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About 4D Molecular Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy 4D Molecular Therapeutics (FDMT) stock?
You can purchase shares of 4D Molecular Therapeutics (NASDAQ: FDMT) through any online brokerage.
Who are 4D Molecular Therapeutics's (FDMT) competitors?
Other companies in 4D Molecular Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Gyre Therapeutics (NASDAQ:GYRE), Immatics (NASDAQ:IMTX), Prothena Corp (NASDAQ:PRTA) and Day One Biopharmaceutical (NASDAQ:DAWN).
What is the target price for 4D Molecular Therapeutics (FDMT) stock?
The latest price target for 4D Molecular Therapeutics (NASDAQ: FDMT) was reported by RBC Capital on Monday, April 15, 2024. The analyst firm set a price target for 40.00 expecting FDMT to rise to within 12 months (a possible 57.54% upside). 19 analyst firms have reported ratings in the last year.
Current Stock Price for 4D Molecular Therapeutics (FDMT)?
The stock price for 4D Molecular Therapeutics (NASDAQ: FDMT) is $25.39 last updated April 23, 2024 at 6:02 PM EDT.
Does 4D Molecular Therapeutics (FDMT) pay a dividend?
There are no upcoming dividends for 4D Molecular Therapeutics.
When is 4D Molecular Therapeutics (NASDAQ:FDMT) reporting earnings?
4D Molecular Therapeutics’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
Is 4D Molecular Therapeutics (FDMT) going to split?
There is no upcoming split for 4D Molecular Therapeutics.
What sector and industry does 4D Molecular Therapeutics (FDMT) operate in?
4D Molecular Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.